TRIM16 deficiency significantly exacerbates cardiomyocyte hypertrophy, while overexpression of TRIM16 inhibits cardiac hypertrophy, suggesting that a TRIM16 inhibitor could be a novel inhibitor of pathological heart hypertrophy and heart failure (Liu J. et al., 2022). This evidence concerns the gene TRIM16 and heart failure.